| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.28 | 6e-05 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.13 | 8e-05 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |